CHRONIC: Beta‐blockers may leads to lower cardiovascular death ( compared with placebo (low certainty).
It is very uncertain whether primary‐level worker‐led collaborative care changes adverse events ‐ death compared with usual care (very low certainty).
The intervention probably leads to lower death from pericarditis (moderate certainty).
It is very uncertain whether the intervention changes death from pericarditis (very low certainty).
Psychological intervention with or without other rehabilitation may leads to lower cardiac mortalityDeaths compared with control (usual care/other rehabilitation) (low certainty).
One intervention showed no clear difference in pregnancy‐related deaths compared with no intervention (low certainty).
It is very uncertain whether unfractionated heparin changes death: unknown time frame compared with low molecular weight heparin (very low certainty).
Counselling showed no clear difference in death (any cause) (median compared with usual care (low certainty).
Cognitive‐behavioural therapy showed no clear difference in death (any cause) (median compared with usual care (low certainty).
Acupuncture showed no clear difference in stillbirth and neonatal death compared with placebo (low certainty).
Corticosteroids showed no clear difference in stillbirth and neonatal death compared with promethazine (low certainty).
It is very uncertain whether corticosteroids changes stillbirth and neonatal death compared with placebo (very low certainty).
It is very uncertain whether intervention changes all‐cause mortality (deaths) Â compared with usual care (very low certainty).
Cyclosporin showed no clear difference in CKD or death: death by 52 weeks compared with mycophenolate mofetil with pulse dexamethasone (low certainty).
Work‐directed counselling showed no clear difference in adverse effects: cardiac deaths compared with usual care (moderate certainty).
The intervention showed no clear difference in intrapartum and neonatal deaths (high certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether long (> 20 cm) changes death from any cause at day 28 of compared with short (≤ 20 cm) catheter (very low certainty).
It is very uncertain whether surface‐modified changes death from any cause at day 28 of compared with standard double‐lumen catheter with identical geometry and flow design (very low certainty).